| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.0057 | 0.9 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | -0.0056 | 0.9 |
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | -0.0061 | 0.9 |
| mRNA | R428 | CTRPv2 | pan-cancer | AAC | -0.0065 | 0.9 |
| mRNA | PD173074 | GDSC1000 | pan-cancer | AAC | -0.0053 | 0.9 |
| mRNA | importazole | CTRPv2 | pan-cancer | AAC | -0.0057 | 0.9 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | -0.0056 | 0.9 |
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | -0.005 | 0.9 |
| mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | -0.0064 | 0.9 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.0065 | 0.9 |